26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NMR of <strong>Peptide</strong>s 105<br />

Fig. 13. Proposed distribution of furylacryloyl phenylalanine (left) and captopril<br />

(right) between the binding sites of ACE, as determined by trNOESY experiments.<br />

(Adapted from ref. 76).<br />

at cis proline at position 13. The turn is oriented at ∼90 ◦ in respect to the plane<br />

of the �-strands.<br />

The use of trNOESY experiments for screening purposes was first demonstrated<br />

on carbohydrates binding to a lectin, an interaction that usually<br />

is of medium to low affinity (75). Meyer et al. were able to identify a<br />

binding carbohydrate from two carbohydrate libraries. In another experiment<br />

Mayer et al. employed trNOESY experiments to determine the affinity and<br />

subsite selectivity of derivatives of dipeptides and amino acids binding to the<br />

angiotensin-converting enzyme (ACE). In their study they identified the highestaffinity<br />

ligand from a small library of compounds. Using mixtures of amino acid<br />

derivatives with and without additional dipeptides or one derivatized amino acid<br />

and captopril, they were also able to determine the distribution of the peptides<br />

between the different binding sites in the active site of ACE (76). Their proposal<br />

for the distribution of furylacryloyl-phenylalanine and captopril between the<br />

binding sites of ACE is shown in Fig. 13.<br />

5.2. Cyclic RGD <strong>Peptide</strong>s Binding to Integrin Studied by STD NMR<br />

The RGD motif has long been known to be the principal binding motif of<br />

several integrins (77). Aumailly et al. showed that the cyclic peptide c(RGDfV),<br />

where f denotes d-phenylalanine (D-Phe), is a potent inhibitor of the integrin<br />

�IIb�3 and determined the three-dimensional structure of the cyclic peptide from

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!